Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan in AIDS-Related PML
NCT00002395Phase 2Completed
- Sponsor
- GSK
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of topotecan in progressive multifocal leukoencephalopathy (PML) (2 arms), sponsored by GSK. Status: completed.
02
Drugs
topotecan
03
Conditions
progressive multifocal leukoencephalopathy (PML)
Beyond the preview
Go deeper on NCT00002395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002395.